The story of Viagra, formerly marketed by copyright, presents a intricate case study for investors considering the pharmaceutical sector. Although its groundbreaking success and creation of vast in revenue , the exclusivity lapse has opened the door for generic medications, greatly reducing profit prospects . This transition raises concerns about t